RSV-F vaccine: Phase II started

Novavax began a single-blind, placebo-controlled, U.S. Phase II trial to evaluate intramuscular 120 Ug RSV-F vaccine with 0.4 mg aluminum adjuvant in about 50 healthy women in the third trimester of p...